Health Care·Managed Health Care·$74.9B
Elevance Health Inc (ELV) is a major player in the managed health care sector, providing health insurance and related services. With a market cap of $71 billion, the company is significant in shaping health care access and affordability, especially as the industry navigates regulatory changes and rising consumer demand for health services.
Earnings Per Share (EPS)
EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.
Membership Growth
Growth in membership can indicate the company's ability to attract and retain customers, which is crucial for revenue stability.
1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.
Elevance Health Inc (ELV) is a major player in the managed health care sector, providing health insurance and related services. With a market cap of $71 billion, the company is significant in shaping health care access and affordability, especially as the industry navigates regulatory changes and rising consumer demand for health services.
EPS Beat Streak
3Q
EPS Beat Rate
63%
Avg EPS Surprise
+3.63%
Avg Stock Reaction
-2.37%
In Q4 2025, Elevance Health reported an EPS of $3.33, exceeding expectations by 7.28%. The stock reacted positively, gaining 5.86% the following day.
Management Promises & Guidance
Overall, analysts are cautiously optimistic about Elevance Health's upcoming earnings, given their recent performance. However, uncertainty remains due to the lack of specific guidance.
Bull Case
If Elevance can demonstrate strong membership growth and maintain a favorable medical loss ratio, it could signal robust demand and operational efficiency, leading to a positive market reaction.
Bear Case
Conversely, if the company reports disappointing membership numbers or a high medical loss ratio, it could raise concerns about profitability and market competitiveness, leading to a negative reaction.
Earnings Per Share (EPS)
N/AEPS is a key indicator of the company's profitability and financial health, which investors closely monitor.
Membership Growth
N/AGrowth in membership can indicate the company's ability to attract and retain customers, which is crucial for revenue stability.
Medical Loss Ratio (MLR)
N/AMLR measures the percentage of premiums spent on medical care, impacting profitability and regulatory compliance.
The print will turn on these two things.
Q1
What is the growth rate of membership this quarter?
Membership growth is crucial for revenue and indicates the company's competitive position in the market.
Q2
What is the current medical loss ratio?
A high medical loss ratio could signal potential profitability issues, which investors will closely watch.
Why consensus could be wrong
The Street may underestimate the impact of recent health care reforms that could drive membership growth higher than expected.
Supporting Evidence
Recent trends in health care spending suggest increased demand for managed care services.
Elevance's recent performance shows a strong ability to adapt to market changes, which may not be fully reflected in current estimates.
Key Risk
If membership growth exceeds 5%, it could challenge current bearish sentiment.
Pre-commit to what would confirm each case.
This quarter's performance will hinge on membership growth and the medical loss ratio, both critical indicators of Elevance's operational health.
Bull Confirmed If
Membership growth of 5% or more compared to the previous quarter would confirm the bull case.
Bear Confirmed If
A medical loss ratio exceeding 85% would confirm the bear case.
Implied Move
±3.1%
Historical Avg
±5.1%
The options market is pricing in a modest move of around 3.1%, suggesting that traders expect limited volatility around the earnings report.
Options are pricing ±3.1% while ELV has averaged ±5.1% over the last 8 prints — setup is pricing cheap.
Likely market behavior by outcome — not investment advice.
Beat & Raise
If Elevance beats expectations, history suggests the stock could rise by an average of 1.17%, confirming strong operational performance.
In-Line / Cautious
If results are in line but management provides cautious commentary, the stock may see muted movement as investors digest the outlook.
Miss
A miss could lead to a decline of around 11.40%, reflecting investor disappointment and concerns over future growth.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ZIONS BANCORP N A
Apr 20, 2026